Difelikefalin for itching in hemodialysis patients
Part of Kidney & urinary, Skin clinical trials.
This trial tests a drug called difelikefalin to see if it can reduce severe itching in people on hemodialysis for chronic kidney disease. If you have troublesome itching despite dialysis, this treatment might help relieve it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to have chronic kidney disease and be on hemodialysis for at least 3 months.
- Your itching should be moderate to severe, meaning a score of at least 4 out of 10 on a 0–10 scale.
- Your itching should not be due to a skin disease, liver problem, thyroid problem, or low iron levels.
- You must not be allergic to opioid medications.
- If pregnant, you are not eligible. Also, no drug abuse or substance dependence.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is common in kidney disease, and this study aims to find a new treatment option.
This study tests a medication called nalfurafine to see if it can reduce severe itching (pruritus) that often comes with advanced kidney disease in people on dialysis. If you have moderate to severe itching and have been on dialysis twice a week for more than 6 months, this trial may offer a potential new treatment option.
This study tests a new oral medication, nalfurafine hydrochloride, to see if it helps reduce itching in people on dialysis. It might offer a new option for those whose current itch treatments haven't been effective.
This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.
This trial tests if anrikefon or nalfurafine improves sleep quality in people on hemodialysis who have chronic kidney disease-related itching. It aims to find a better treatment for both itch and sleep problems.
This study tests a special type of dialysis filter (made of PMMA) to see if it can reduce severe itching and improve quality of life for people on long-term dialysis. If you have bothersome itching that standard treatment hasn't helped, this trial might be an option for you.
Hear when a new CKD 5D, Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.